Truth Initiative Urges Stronger FDA Review of New Tobacco
Washington, D.C., U.S., September 28, 2026 The U.S. Food and Drug Administration’s approach to regulating new tobacco products is...
Regulatory Science
Advertisement
Boehringer Ingelheim Launches PED Essentials for Patient Evidence
INGELHEIM, Germany — September 17, 2026 Boehringer Ingelheim announced the launch of PED Essentials, a free online learning hub...
FDA Seeks Input on Generative AI Medical Device Rules
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
FDA Expands Regulatory Flexibility for Cell and Gene Therapies
White Oak, Maryland – January 2026 — The U.S. Food and Drug Administration has announced a more flexible regulatory...
uBriGene Launches GMP LVV Turbo Platform with UltraCell Integration
CAMBRIDGE, Massachusetts, December 17, 2025 — uBriGene, a leader in advanced biopharmaceutical manufacturing, has launched LVV Turbo™, its next-generation...
Advertisements
Envoy Medical Secures Patent Advancing Cochlear Implant Signal Quality
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
CTT Pharma Publishes Peer-Reviewed Drug Delivery Research
BOSTON, Massachusetts — December 16, 2025 — CTT Pharmaceutical Holdings, Inc. (CTT Pharma) announced that its scientific team has...
In-Silico Trials Surge as AI Transforms Drug & Device R&D
AUSTIN, Texas & TOKYO — November 27, 2025. A new global analysis reports that the In-Silico Clinical Trials (IST)...
FDA Approves TEZSPIRE for Chronic Rhinosinusitis with Nasal Polyps
THOUSAND OAKS, Calif., October 17, 2025 — In a landmark regulatory decision, the U.S. Food and Drug Administration (FDA)...
Novavax’s Nuvaxovid™ 2025–2026 Formula COVID-19 Vaccine Approved in the U.S.
GAITHERSBURG, Md., August 27, 2025 – The U.S. Food and Drug Administration (FDA) has granted approval for Novavax’s Nuvaxovid™...
Advertisement
